SCHEMBL3198068

SCHEMBL3198068

[NH][C@@H]1CC2CCN1CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1920414 1.00
SCHEMBL3206997 0.82
SCHEMBL4279010 0.67 SLC18A3 (0.35)
SCHEMBL3198076 0.62
SCHEMBL9236734 0.62
SCHEMBL9550980 0.62
SCHEMBL728782 0.62
SCHEMBL8340377 0.62
SCHEMBL731350 0.62
SCHEMBL3277616 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7683075-B2 Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof NOVARTIS AG (CH) 2010-03-23 US disclosed
US-20070142428-A1 Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof NOVARTIS AG (CH) 2007-06-21 US disclosed
EP-1633752-A1 ISOQUINOLINE-3-CARBOXYLIC ACID AMIDES AND PHARMACEUTICAL USES THEREOF Novartis AG (CH) 2006-03-15 EP disclosed
WO-2004099206-A1 ISOQUINOLINE-3-CARBOXYLIC ACID AMIDES AND PHARMACEUTICAL USES THEREOF NOVARTIS AG (CH) 2004-11-18 WO disclosed